(24/7 MARKET NEWS) – BioRestorative Therapies, Inc. (NASDAQ:BRTX) announced, this morning, that the United States Patent and Trademark Office issued a notice of allowance for a patent application related to the Company’s metabolic ThermoStem program. The notice of allowance will be the third US patent to issue from this ThermoStem family targeting obesity and metabolic disorders, including type 2 diabetes, and was issued on February 24, 2023.
BioRestorative Therapies is at $3.32, up $0.53 (+19.00%), on 300 thousand premarket shares.
Its 52-week trading range is $0.3501 to $3.36. It has some weak resistance around the $3.50 level and stronger resistance around $4. If it can break through the $4 resistance level, on strong trading volume, it may try to challenge the $5 trading level.
24/7 MARKET NEWS, INC Disclaimer
24/7 MARKET NEWS (“24/7 MN”) is dedicated to covering various underreported segments of the stock markets. Our goal is to help you to better understand these markets, but 24/7 MN is neither an investment advisor nor a financial advisor, and no information provided here is to be interpreted as a suggestion to buy or sell stocks or other investment products. All opinions, news, research, analysis, prices or other information contained on 247marketnews.com, its press releases, or other services are provided for educational purposes only and do not constitute investment advice. You are solely responsible for the investment decisions you make.
Please go to www.247marketnews.com or https://www.247marketnews.com/terms-disclaimer/ for further information.
